Biopharma entrepreneurs! LaunchBio's expert VC panelists are answering your questions, reflecting on the impact on investments during Covid-19 and what the future holds for IPOs and M&A. Walk through top biopharma fund initial assessment through due diligence and investment. Learn where investors are finding technology, how they are valuing and deciding on opportunities, and how they look at team versus asset/technology.
- Jonathan Norris, Managing Director, Healthcare Practice, SVB
- Otello Stampacchia, PhD, Founder, Omega Funds
- Deborah Palestrant, PhD, Partner, Head of 4:59, 5AM Ventures
- Cami Samuels, Partner, Venrock
- Dan Estes, PhD, General Partner - Frazier Healthcare Partners